Latest & greatest articles for constipation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on constipation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on constipation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for constipation

41. Clinical Practice Guideline for the Evaluation and Management of Constipation

Clinical Practice Guideline for the Evaluation and Management of Constipation Copyright © The American Society of Colon & Rectal Surgeons, Inc. Unauthorized reproduction of this article is prohibited. 479 Diseases of the Colon & ReCtum Volume 59: 6 (2016) t he a merican s ociety of Colon and Rectal surgeons is dedicated to assuring high-quality patient care by advancing the science, prevention, and manage- ment of disorders and diseases of the colon, rectum, and anus. t he Clinical Practice (...) - ment regarding the propriety of any specific procedure must be made by the physician in light of all of the cir- cumstances presented by the individual patient. STATEMENT OF THE PROBLEM Constipation is a benign condition that can have a signifi- cant impact on quality of life. t he prevalence has been es- timated to be as high as 30% in select populations and has been noted to be higher in women, nonwhites, those aged >65 years, and those with lower socioeconomic status. 1–6 Constipation

American Society of Colon and Rectal Surgeons2016

43. Interventions for treating constipation in pregnancy.

Interventions for treating constipation in pregnancy. BACKGROUND: Constipation is a common symptom experienced during pregnancy. It has a range of consequences from reduced quality of life and perception of physical health to haemorrhoids. An understanding of the effectiveness and safety of treatments for constipation in pregnancy is important for the clinician managing pregnant women. OBJECTIVES: To assess the effectiveness and safety of interventions (pharmacological and non-pharmacological (...) ) for treating constipation in pregnancy. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2015), ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) (30 April 2015) and reference lists of retrieved studies. SELECTION CRITERIA: We considered all published, unpublished and ongoing randomised controlled trials (RCTs), cluster-RCTs and quasi-RCTs, evaluating interventions (pharmacological and non-pharmacological

Cochrane2015

44. Linaclotide (Constella) in the symptomatic management of irritable bowel syndrome with constipation, The indication was granted...so what?

Linaclotide (Constella) in the symptomatic management of irritable bowel syndrome with constipation, The indication was granted...so what? 2015. DAR No 4: Linaclotide. Constella® in the symptomatic management of irritable bowel syndrome with constipation - navarra.es Castellano | Euskara | Français | English Use the search tool! Search engine : : : : : : : : DAR No 4: Linaclotide. Constella® in the symptomatic management of irritable bowel syndrome with constipation DAR No 4: Linaclotide (...) . Constella® in the symptomatic management of irritable bowel syndrome with constipation Content tools Share it The indication was granted...so what? Although authorized for irritable bowel syndrome with constipation it offers only symptomatic relief. In the best of cases, one in five patients can benefit from treatment. On the other hand, one in five patients can suffer from diarrhea as a secondary effect which can last for more than 28 days in half the cases. There are no available studies evaluating

Drug and Therapeutics Bulletin of Navarre (Spain)2015

45. Sacral nerve stimulation for faecal incontinence and constipation in adults.

Sacral nerve stimulation for faecal incontinence and constipation in adults. BACKGROUND: Faecal incontinence (FI) and constipation are both socially-embarrassing and physically-disabling conditions that impair quality of life. For both, surgery may be required in a minority of people when more conservative measures fail. However, the invasiveness and irreversible nature of direct surgery on bowel and sphincter muscles, poor long-term outcomes and well-established compIications makes (...) such procedures unappealing for these benign conditions. A less-invasive surgical option to treat faecal incontinence and constipation is direct, low-voltage stimulation of the sacral nerve roots, termed sacral nerve stimulation (SNS). SNS has become the first line surgical treatment for FI in people failing conservative therapies. Its value in the treatment of constipation is less clear. OBJECTIVES: To assess the effects of sacral nerve stimulation using implanted electrodes for the treatment of faecal

Cochrane2015

46. Constipation Associated with a Lipoma.

Constipation Associated with a Lipoma. IMAGES IN CLINICAL MEDICINE. Constipation Associated with a Lipoma. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26267625 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 13;373(7):656. doi: 10.1056/NEJMicm1413283. IMAGES IN CLINICAL MEDICINE. Constipation Associated with a Lipoma. 1 , . 1 Naval Medical Center Portsmouth, Portsmouth, VA curtis.hardy@me.com. PMID: 26267625 DOI: [Indexed for MEDLINE] Free full text Publication type MeSH terms Full Text Sources Medical PubMed Commons 0

NEJM2015 Full Text: Link to full Text with Trip Pro

47. Naloxegol for treating opioid-induced constipation

Naloxegol for treating opioid-induced constipation Nalo Nalox xegol for treating opioid-induced egol for treating opioid-induced constipation constipation T echnology appraisal guidance Published: 22 July 2015 nice.org.uk/guidance/ta345 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful (...) a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Naloxegol for treating opioid-induced constipation (TA345) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 43Contents Contents 1 Guidance 4 2 The technology 5 3 The company's submission 6 Clinical effectiveness 6 Evidence Review

National Institute for Health and Clinical Excellence - Technology Appraisals2015

48. Polyethylene Glycol for the Treatment of Constipation in Patients in Acute and Long-Term Care: Cost-Effectiveness and Guidelines

Polyethylene Glycol for the Treatment of Constipation in Patients in Acute and Long-Term Care: Cost-Effectiveness and Guidelines Polyethylene Glycol for the Treatment of Constipation in Patients in Acute and Long-Term Care: Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Polyethylene Glycol for the Treatment of Constipation in Patients in Acute and Long-Term Care: Cost-Effectiveness and Guidelines Polyethylene Glycol for the Treatment of Constipation in Patients (...) in Acute and Long-Term Care: Cost-Effectiveness and Guidelines Published on: July 14, 2015 Project Number: RA0785-000 Product Line: Report Type: Reference List Result type: Report Question What is the cost-effectiveness of polyethylene glycol for the treatment of constipation in adults in acute or long-term care? What is the cost-effectiveness of polyethylene glycol for the treatment of constipation in children in acute or long-term care? What are the evidence-based guidelines regarding the use

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

49. Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association: Clinical Effectiveness and Cost-Effectiveness

Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association: Clinical Effectiveness and Cost-Effectiveness Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association: Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL (...) Association: Clinical Effectiveness and Cost-Effectiveness Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association: Clinical Effectiveness and Cost-Effectiveness Published on: July 7, 2015 Project Number: RA0779-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of the Peristeen anal irrigation system for the management of incontinence

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

50. Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association

Peristeen Anal Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within (...) Irrigation System for the Management of Incontinence and Constipation in Patients with VACTERL Association: Clinical Effectiveness and Cost-Effectiveness DATE: 07 July 2015 RESEARCH QUESTIONS 1. What is the clinical effectiveness of the Peristeen anal irrigation system for the management of incontinence and constipation in patients with VACTERL association? 2. What is the cost-effectiveness of the Peristeen anal irrigation system for the management of incontinence and constipation in patients

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

51. The Diagnostic Value of a Digital Rectal Examination Compared With High-Resolution Anorectal Manometry in Patients With Chronic Constipation and Fecal Incontinence

The Diagnostic Value of a Digital Rectal Examination Compared With High-Resolution Anorectal Manometry in Patients With Chronic Constipation and Fecal Incontinence 26032152 2015 08 12 2015 10 26 2017 02 20 1572-0241 110 8 2015 Aug The American journal of gastroenterology Am. J. Gastroenterol. The diagnostic value of a digital rectal examination compared with high-resolution anorectal manometry in patients with chronic constipation and fecal incontinence. 1197-204 10.1038/ajg.2015.153 Digital (...) rectal examination (DRE) is a simple clinical method to diagnose anorectal disorders. High-resolution antorectal manometry (HRAM) based on a spatiotemporal plot is expected to promote improved diagnostic accuracy. However, there are no reports comparing the effectiveness of DRE and HRAM. The aim of our study was therefore to evaluate the diagnostic value of DRE compared with HRAM. A total of 309 consecutive patients with chronic constipation (n=268) or fecal incontinence (n=41) who underwent

EvidenceUpdates2015

52. Laxatives for the management of constipation in people receiving palliative care.

Laxatives for the management of constipation in people receiving palliative care. BACKGROUND: This article describes the second update of a Cochrane review on the effectiveness of laxatives for the management of constipation in people receiving palliative care. Previous versions were published in 2006 and 2010 where we also evaluated trials of methylnaltrexone; these trials have been removed as they are included in another review in press. In these earlier versions, we drew no conclusions (...) on individual effectiveness of different laxatives because of the limited number of evaluations. This is despite constipation being common in palliative care, generating considerable suffering due to the unpleasant physical symptoms and the availability of a wide range of laxatives with known differences in effect in other populations. OBJECTIVES: To determine the effectiveness and differential efficacy of laxatives used to manage constipation in people receiving palliative care. SEARCH METHODS: We searched

Cochrane2015

53. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation 25869393 2015 05 06 2015 07 20 2017 02 20 1572-0241 110 5 2015 May The American journal of gastroenterology Am. J. Gastroenterol. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. 741-8 10.1038/ajg.2015.115 Prucalopride (...) is effective at alleviating symptoms of chronic constipation in women. The aim of this study was to assess the efficacy of 12 weeks of prucalopride treatment compared with placebo in men with chronic constipation. This was a multicenter, stratified, randomized, parallel-group, double-blind, placebo-controlled, phase 3 study (ClinicalTrials.gov identifier: NCT01147926). The primary end point was the proportion of patients with a mean of three or more spontaneous complete bowel movements (SCBMs) per week

EvidenceUpdates2015 Full Text: Link to full Text with Trip Pro

54. Constipation.

Constipation. This issue provides a clinical overview of constipation, focusing on prevention, diagnosis, treatment, and patient information. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including ACP Smart Medicine and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic from these primary sources in collaboration with the ACP's Medical

Annals of Internal Medicine2015

55. Colonoscopy in Patients with Constipation

Colonoscopy in Patients with Constipation Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along with other types (...) , posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions. TITLE: Colonoscopy in Patients with Constipation: Clinical Effectiveness and Guidelines DATE

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

56. Enemas for the Treatment of Constipation in the Emergency Department

Enemas for the Treatment of Constipation in the Emergency Department Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered (...) study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions. TITLE: Enemas for the Treatment of Constipation

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

57. Systematic review and meta-analysis: Poor quality evidence to support the use of biofeedback for the treatment of functional constipation in adults

Systematic review and meta-analysis: Poor quality evidence to support the use of biofeedback for the treatment of functional constipation in adults Poor quality evidence to support the use of biofeedback for the treatment of functional constipation in adults | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Poor quality evidence to support the use of biofeedback for the treatment of functional constipation in adults Article Text Primary healthcare Systematic review and meta-analysis Poor quality evidence to support the use of biofeedback

Evidence-Based Nursing (Requires free registration)2015

58. Constipation in children

Constipation in children Constipation in children - NICE CKS Clinical Knowledge Summaries Share Constipation in children - Summary Constipation is a decrease in the frequency of bowel movements characterized by the passing of hardened stools which may be large and associated with straining and pain. Normal stool frequency in children ranges from an average of 4 per day in the first week of life to 2 per day at 1 year of age. Passing between 3 stools per day and 3 per week is usually attained (...) by 4 years of age. Constipation is termed idiopathic (functional) if it cannot be explained by any anatomical or physiological abnormality. Contributing factors for constipation include pain, fever, inadequate fluid intake, reduced dietary fibre intake, toilet training issues, the effects of drugs, psychosocial issues, and a family history of constipation. Two or more of the following clinical features indicate that a child is constipated: Fewer than three complete stools per week (unless

NICE Clinical Knowledge Summaries2015

59. Constipation

Constipation Constipation - NICE CKS Clinical Knowledge Summaries Share Constipation - Summary Constipation is defecation that is unsatisfactory because of infrequent stools, difficult stool passage, or seemingly incomplete defecation. Stools are often dry and hard, and may be abnormally large or abnormally small. Functional constipation is chronic constipation without a known cause. Secondary constipation is caused by a drug or medical condition (such as endocrine and metabolic diseases (...) , myopathic and neurological conditions, and certain bowel conditions). Faecal loading/impaction is retention of faeces to the extent that spontaneous evacuation is unlikely. Constipation is common at all ages especially in women, the elderly, and during pregnancy. Assessment should determine: The person’s understanding of constipation. The severity and impact of the constipation, and the presence and degree of faecal impaction and faecal incontinence. The role of predisposing factors. If there are any

NICE Clinical Knowledge Summaries2015

60. Treatments for Constipation

Treatments for Constipation TITLE: Treatments for Constipation: A Review of Systematic Reviews DATE: 17 November 2014 CONTEXT AND POLICY ISSUES Constipation has many definitions and is often described differently depending on the population queried. Physicians may define constipation as a reduction in the frequency of bowel movements to fewer than three times per week while patients identify more with the symptoms associated with constipation such as difficulty passing stool, hard stool (...) consistency, feelings of abdominal cramping, and feelings of incomplete stool passage. 1 Causes of constipation may be primary (idiopathic) or secondary to other factors such as diet, medication, or medical conditions. 2 Constipation can affect anyone as a minor annoyance but up to a quarter of the population experiences it chronically or severely. 2 It can substantially affect quality of life and be debilitating. 2 It is estimated that between 2% to 27% of the population are affected depending upon

Canadian Agency for Drugs and Technologies in Health - Rapid Review2014